Business Wire

AMGTA Releases First Commissioned Research Paper

Share

The Additive Manufacturer Green Trade Association (“AMGTA”), a global advocacy group focused on developing and promoting sustainable additive manufacturing industry practices, announced today that it had published its first independent piece of research, titled “Comparative LCA of a Low-Pressure Turbine (LPT) Bracket by Two Manufacturing Methods.” The report, commissioned by the AMGTA and authored by the Rochester Institute of Technology’s Golisano Institute of Sustainability, analyzed a commercial aerospace low-pressure turbine bracket via a life cycle assessment (“LCA”), evaluating both (i) the comparative manufacturing impact of laser powder bed fusion (“LPBF”) additive manufacturing (“AM”) vs. traditional manufacturing of the bracket and (ii) the impact of a greater than 50% weight reduction of the bracket over the life of the aircraft. While the comparative end result was inconclusive with regard to which manufacturing method used more energy, the results confirmed the dramatic impact that lightweighting commercial aircraft engines and airframes have on carbon emissions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230410005344/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

A comparison of the AM-designed bracket (left) and the traditional version (right). (Photo: Business Wire)

Key takeaways from the LCA included the following points.

  • Inconclusive on Manufacturing Method. Using three separate methodologies, the LCA was inconclusive as to which manufacturing method (traditional or additive) used more energy. On balance, this neutral finding represented an improvement over previous studies showing higher energy used in LPBF manufacturing compared to traditional methods.
  • Importance of Energy Mix. The study found that by far the biggest factor in determining sustainability of production was a manufacturing facility’s energy mix at the location of generation, and whether that energy grid was produced using sustainable means.
  • Outsized Impact on Lightweighting Aircraft. The study very clearly showed that lightweighting aircraft components via AM design resulted in a dramatic reduction in carbon emissions over the life of an aircraft, with a reduction of 13,376 kg for every 1 kg of weight reduction.
  • Overall, AM Produced a More Sustainable Part. The impact of lightweighting by far was the most important factor in determining that AM-produced components are more sustainable than a traditionally designed and manufactured part.

“The release of this peer-reviewed LCA—the first of its kind—represents a milestone for the AMGTA,” said Sherri Monroe, the AMGTA’s Executive Director. “For the first time, we are able to publish tangible results demonstrating the importance of design in additive manufacturing when compared to traditional methods. This study demonstrates the very real impact that AM can have in aircraft and engine design of the future, and bodes well for using similar strategies in other industries and programs.”

The two-year study analyzed the two brackets using three LCA methodologies, including the ReCiPe 2016 version 1.1 midpoint method, the Cumulative Energy Demand v1.11, and the Intergovernmental Panel on Climate Change’s IPCC 2021 GWP100 methods. Two of the three methods indicated that, strictly from a manufacturing standpoint, the traditional bracket required less energy to produce, while one method indicated that the AM version produced less carbon dioxide. In all cases, however, the results indicated that the energy mix of the underlying electrical grid had an outsized effect on the sustainability of the manufacturing process. The LCA was performed in accordance with ISO 14040:2006(E) and was peer-reviewed by EarthShift Global.

The underlying bracket, which is one of 12 on each of the two GE Aviation CF6-80C2B6F turbine engines powering a Boeing 767 aircraft, secures a fuel manifold to the external case of the engine’s low pressure turbine module. It was selected by the AMGTA because it was a relatively simple part that is easy to access and locate. The additive design and manufacturing of the bracket was performed by Sintavia, LLC in Hollywood, Florida, and printed on an EOS GmbH M290 printer using Höganäs AB Inconel 718 powder. The traditional part was manufactured by a Tennessee-based machine shop using a CNC process. The optimized AM bracket was over 50%, or 0.063 kg, lighter than the original version. According to Sintavia, the optimized bracket outperformed the traditional bracket in terms of mechanical properties, with an increased fatigue life in spite of its reduced weight.

While the choice of the LPT bracket offered a simple demonstration of how lightweighting could work on an aircraft engine, the AMGTA believes that the lessons embodied in the current LCA could be much more widely adopted by airframers and engine manufacturers across multiple mechanical systems. Moreover, lightweighting methods of transportation using additive design technology is not only limited to LPBF AM, as other additive technologies (including binder jetting, directed energy deposition, and polymer printing) can similarly remove excess weight across vehicles, aircraft, and vessels.

“This study underscores the importance of using AM to develop optimized parts and components that have been lightweighted via AM technology,” said Brian Neff, Sintavia’s CEO and the Chair of the AMGTA. “No other currently viable commercial technology offers such an immediate impact to carbon emissions as lightweighting aircraft parts via AM does, and we now have independently verified, peer-reviewed data proving so. We look forward to working with Boeing, GE, and all of the industry’s OEMs as they look to unleash the sustainable potential of AM across existing and future platforms.”

“The two phases of this study - production and use – have implications well beyond this specific bracket, airplane, or manufacturing sector,” Sherri Monroe added. “The negligible difference in environmental impacts during production combined with the benefits of on-demand production – when you want it, where you want it, how you want it – to deliver more resilient, efficient, and sustainable supply chains, have significant implications for the manufacturing ecosystem to deliver more sustainable solutions.”

“While this study has immediate implications for aircraft engine and airframe manufacture, the findings in the use phase extend to any part of an airplane that could potentially be lightweighted – mechanical systems, seats, service carts, galleys – and well beyond aircraft to any equipment moved by an engine or motor – vehicles, ships, trains, robots – although the energy demands for aerospace make it the biggest, most obvious and most immediate beneficiary.”

The AMGTA says that it expects to publish additional independent research throughout 2023. Additional information on the LCA can be found on the AMGTA website, www.amgta.org.

About the AMGTA

The AMGTA was launched in 2019 to better understand and promote the environmental benefits of additive manufacturing across the global economy. AMGTA members represent the entirety of the manufacturing spectrum - from design and raw materials to end products and users - focused on innovating better, more sustainable, and financially advantageous products through best additive practices. For more information, please contact Sherri Monroe or visit www.amgta.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Caitlyn Perry, +1 954.308.0888
info@amgta.org

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 03:09:00 EEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio ha

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye